CLARISCAN SOLUTION FOR INJECTION IN VIAL 0.5 MMOL/ML
Product details
Registration number: SIN15693P
Classification: Prescription Only
Active ingredients: Gadoterate meglumine 376.9mg/ml eqv Gadoteric acid
Strength: 279.32mg/ml
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS
Registrant: GE HEALTHCARE PTE. LTD.
ATC code: V08CA02
HSA approval date: 24 May 2019
Manufacturer(s): GE Healthcare AS (Oslo Site)
Manufacturing country/countries: NORWAY
What are the HSA registration number and classification for CLARISCAN SOLUTION FOR INJECTION IN VIAL 0.5 MMOL/ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15693P
Classification: Prescription Only
What active ingredients and strength are recorded for CLARISCAN SOLUTION FOR INJECTION IN VIAL 0.5 MMOL/ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Gadoterate meglumine 376.9mg/ml eqv Gadoteric acid
Strength: 279.32mg/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for CLARISCAN SOLUTION FOR INJECTION IN VIAL 0.5 MMOL/ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for CLARISCAN SOLUTION FOR INJECTION IN VIAL 0.5 MMOL/ML?
According to the HSA dataset updated 7 August 2026:
Registrant: GE HEALTHCARE PTE. LTD.
Which manufacturers and countries are listed for CLARISCAN SOLUTION FOR INJECTION IN VIAL 0.5 MMOL/ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): GE Healthcare AS (Oslo Site)
Manufacturing country/countries: NORWAY
Where can I look up CLARISCAN SOLUTION FOR INJECTION IN VIAL 0.5 MMOL/ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15693P or the exact product name CLARISCAN SOLUTION FOR INJECTION IN VIAL 0.5 MMOL/ML. The general register link does not preselect this product.
What are the source dates for this CLARISCAN SOLUTION FOR INJECTION IN VIAL 0.5 MMOL/ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this CLARISCAN SOLUTION FOR INJECTION IN VIAL 0.5 MMOL/ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15693P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)